Anchor-compound logic: why the blend is set by GHK-Cu KLOWs fixed 0.10 mL dose is calibrated around GHK-Cu as the anchor compound
Safety concerns included uncharacterized immunogenicity (the risk that injected peptides trigger immune reactions), inadequate impurity and endotoxin testing in available raw material, the unresolved free base versus acetate salt form distinction, and, for BPC-157 specifically, an angiogenesis mechanism that raises theoretical cancer-risk concerns for certain patient populations
To view or add a comment, sign in More Relevant Posts Diabetes management isnt just about lowering blood sugarits about choosing the right drug with the right mechanism
Early detection and treatment of a B12 deficiency are important
Do not use if the safety seal is broken
PubMed 18068698 TB-4 / TB-500 product mislabeling documented bidirectional mislabeling between full-length TB-4 (43 aa) and the TB-500 fragment (residues 1723) in marketed peptide products: Esposito M et al